Gion M, Mione R, Pappagallo G L, Gatti C, Nascimben O, Sampognaro E, Meo S
Center for the Study of Biological Markers of Malignancy, General Regional Hospital, Venice, Italy.
Anticancer Res. 1994 Mar-Apr;14(2B):693-8.
We evaluated the prognostic value of tissue polypeptide antigen (TPA), cathepsin D and pS2 in 267 patients operated for primary breast cancer. Cathepsin D, pS2 and cytosol TPA were independent of each other and of N, T, estrogen (ER) and progesterone (PgR) receptors. Cathepsin D was the best prognostic indicator for disease-free survival and pS2 for overall survival. The simultaneous evaluation of the three parameters was an effective discriminator between high and low risk patients in both N- and N+. Considering that cathepsin D, pS2 and cytosol TPA can be easily measured with reliable methods in small amounts of tissue, we conclude that they are a promising panel of biochemical parameters suitable for the assessment of the risk of relapse in patients with breast cancer.
我们评估了组织多肽抗原(TPA)、组织蛋白酶D和pS2在267例接受原发性乳腺癌手术患者中的预后价值。组织蛋白酶D、pS2和胞质TPA相互独立,且与N、T、雌激素(ER)和孕激素(PgR)受体无关。组织蛋白酶D是无病生存的最佳预后指标,pS2是总生存的最佳预后指标。同时评估这三个参数能有效区分N-和N+患者中的高风险和低风险患者。鉴于组织蛋白酶D、pS2和胞质TPA可以通过可靠方法在少量组织中轻松测量,我们得出结论,它们是一组很有前景的生化参数,适用于评估乳腺癌患者的复发风险。